Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus

Journal of Viral Hepatitis

Volumn 22, Issue 10, 2015, Pages 828-834

  Andersen, Ellen S ^a,b   Omland, L H ^a   Jepsen, P ^c   Krarup, H ^d   Christensen, P B ^e   Obel, N ^a   Weis, N ^b,f  

^a Rigshospitalet   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cancer; hepatitis B virus; hepatocellular carcinoma; non Hodgkin lymphoma; pancreatic cancer

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL EVALUATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; ADOLESCENT; COMPLICATION; DENMARK; INCIDENCE; LIVER NEOPLASMS; LONGITUDINAL STUDY; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PANCREATIC NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; DENMARK; FEMALE; HEPATITIS B; HUMANS; INCIDENCE; LIVER NEOPLASMS; LONGITUDINAL STUDIES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK ASSESSMENT; YOUNG ADULT;

EID: 84941187056     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12391     Document Type: Article

References (32)

1. WHO. WHO fact sheet N°204, revised. 2013.
2. Ito K, Arai M, Imazeki F, et al,. Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Scand J Gastro 2010; 45: 243-249.
3. Chen CJ, Yang HI, Su J, et al,. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
4. Bortolotti F, Cadrobbi P, Crivellaro C, et al,. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B infection in childhood. Gastroenterology 1990; 99: 805-810.
5. Thein HH, Walter SR, Gidding HF, et al,. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a populations-based cohort study, 1992-2007. J Viral Hepat 2011; 18: e232-e241.
6. Sakuma K, Saitoh N, Kasai M, et al,. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 1988; 8: 1642-1646.
7. Villeneuve JP, Desrochers M, Infante-Rivard C, et al,. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106: 1000-1005.
8. Sherman M, Peltekian KM, Lee C,. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 432-438.
9. Amin J, Dore GJ, O'Connell DL, et al,. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006; 45: 197-203.
10. Sundquist K, Sundquist J, Ji J,. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden. J Med Vir 2014; 86: 18-22.
11. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C,. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 1984; 65: 651-656.
12. Hoefs JC, Renner IG, Askhcavai M, Redeker AG,. Hepatitis B surface antigen in pancreatic and biliary secretions. Gastroenterology 1980; 79: 191-194.
13. Yood MU, Quesenberry CP Jr, Guo D, et al,. Incidence of Non-Hodgkin's lymphoma among Individuals with chronic hepatitis B virus infection. Hepatology 2007; 46: 107-112.
14. Becker N, Schnitzler P, Boffetta P, et al,. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol 2012; 138: 1993-2001.
15. Engels EA, Cho ER, Jee SH,. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 2010; 11: 827-834.
16. Hassan MM, Li D, El-Deeb AS, et al,. Association between hepatitis B and pancreatic cancer. J Clin Oncol 2008; 26: 4557-4562.
17. Iloeje UH, Yang HI, Jen CL, et al,. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int 2010; 30: 423-429.
18. Statistics Denmark. 2012. Available at: http://www.statistikbanken.dk/statbank5a/default.asp?w=1280 (accessed 10 Oct 2013).
19. Omland LH, Jepsen P, Skinhoj P, et al,. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study. HIV Med 2009; 10: 65-71.
20. Epidemiology FL,. When an entire country is a cohort. The Lancet 2000; 287: 2398-2399.
21. The Central Office of Civil Registration. The Civil Registration System in Denmark. 2012. Available at: http://www.cpr.dk/cpr/site.aspx?p=34 (accessed 10 Oct 2013).
22. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH,. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
23. Gjerstorff ML,. The Danish Cancer Registry. Scand J Public Health 2011; 39: 42-45.
24. Storm HH, Michelsen EV, Clemmensen IH, Pihl J,. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-539.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
26. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA,. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004; 57: 1288-1294.
27. Quan H, Sundararajan V, Halfon P, et al,. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139.
28. Pintelle M,. Competing Risks: A Practical Perspective. Chichester: Wiley, 2006.
29. Chan HL, Hui AY, Wong ML, et al,. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004; 53: 1494-1498.
30. Kim JH, Bang YJ, Park BJ, et al,. Hepatitis B virus infection and b-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002; 93: 471-477.
31. Lim ST, Fei G, Quek R, et al,. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007; 79: 132-137.
32. Anderson LA, Pfeiffer R, Warren JL, et al,. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008; 17: 3069-3075.